The global dental sleep medicine market has reached an estimated $6.65 billion in 2026, driven by rising awareness of obstructive sleep apnea (OSA) and growing patient preference for oral appliance therapy over traditional CPAP machines. A January 2026 JADA cover story synthesizing the American Academy of Dental Sleep Medicine's consensus report reaffirms dentists' expanding role in sleep disorder management — while cautioning that no emerging therapy yet qualifies as a first-line standalone replacement for mandibular advancement devices.
As of August 2026, dental sleep medicine represents one of the fastest-growing intersections of dentistry and general medicine. For Canadian dental professionals — particularly those in Ontario and the Greater Toronto Area — understanding where the field stands, what the evidence supports, and how to integrate sleep screening into clinical practice is no longer optional. It is becoming a core competency.
The Market Trajectory: From Niche to Mainstream
According to The Business Research Company's 2026 report, the dental sleep medicine market grew from $6.22 billion in 2025 to an estimated $6.65 billion in 2026, reflecting a compound annual growth rate of 6.9%. Projections indicate the market will reach $8.69 billion by 2030 at the same rate of growth.
Several factors are converging to fuel this expansion. First, obstructive sleep apnea is increasingly recognized as a significant public health concern, with prevalence estimates suggesting that a substantial portion of the adult population remains undiagnosed. Second, long-term CPAP adherence continues to challenge treatment outcomes — many patients abandon CPAP therapy within the first year due to discomfort, claustrophobia, or lifestyle inconvenience. Third, mandibular advancement devices (MADs) and other oral appliances have accumulated a robust evidence base demonstrating their efficacy for mild-to-moderate OSA and for patients who cannot tolerate CPAP.
Pro Tip: If you are considering adding dental sleep medicine services to your Ontario practice, start by taking a recognized continuing education course through a CDA-accredited provider. The American Academy of Dental Sleep Medicine also offers a Qualified Dentist designation that demonstrates competency to patients and referring physicians.
What the Evidence Actually Supports
The January 2026 JADA cover story provides a critical synthesis of the American Academy of Dental Sleep Medicine's 2024 consensus report on emerging therapies. The review's central finding is clear: no emerging dental therapy has yet demonstrated sufficient evidence to serve as a first-line standalone treatment replacing mandibular advancement devices.
This does not mean progress has stalled. The consensus report identified several emerging approaches — including myofunctional therapy, hypoglossal nerve stimulation coordination with dental care, and positional therapy adjuncts — that may serve individualized or supplementary roles when standard treatments fail or patients decline them. The JADA authors advise that "adoption of new therapies should follow expert consensus and robust evidence until stronger data are available."
For Canadian practitioners, this means that mandibular advancement devices remain the evidence-based standard for dental management of mild-to-moderate OSA. Dentists considering adding emerging therapies should wait for stronger clinical trial data before marketing them to patients as standalone solutions.
Pro Tip: When discussing oral appliance therapy with patients, frame it in terms they understand: a custom-fitted mouthpiece worn during sleep that advances the lower jaw slightly forward to keep the airway open. Patients who have abandoned CPAP are often highly receptive to this alternative when presented with clear, evidence-based information.
The Dentist's Expanding Role in Sleep Health Screening
One of the most significant shifts in dental sleep medicine is the recognition that dentists are uniquely positioned to screen for sleep-disordered breathing. Dental professionals routinely observe anatomical features — tongue size, palatal form, tonsil size, mandibular retrognathia — that correlate with elevated OSA risk. The JADA consensus report explicitly states that dentists play "an increasingly important role in the management of sleep health and disorders."
In practical terms, this means incorporating a validated sleep screening questionnaire (such as the STOP-Bang or Epworth Sleepiness Scale) into new patient intake forms. A positive screening result triggers a referral to a sleep physician for formal diagnosis via polysomnography or home sleep apnea testing — dentists do not diagnose OSA, but they are ideally positioned to identify patients who need evaluation.
In Ontario, the Royal College of Dental Surgeons of Ontario (RCDSO) permits licensed dentists to fabricate and deliver oral appliances for sleep apnea when a physician has provided a diagnosis. The collaborative model — physician diagnosis, dental treatment — is the standard across Canadian provinces and aligns with the Canadian Dental Association's position on the matter.
CPAP Adherence: The Gap That Oral Appliance Therapy Fills
The growth of dental sleep medicine is inseparable from the well-documented limitations of CPAP adherence. CPAP (continuous positive airway pressure) remains the gold standard for moderate-to-severe OSA, but real-world compliance rates tell a different story. Research consistently shows that a significant proportion of patients prescribed CPAP either discontinue use or use it inconsistently. Mask discomfort, noise, nasal congestion, claustrophobia, and lifestyle disruption are among the most commonly cited barriers.
Oral appliance therapy offers a viable alternative for patients with mild-to-moderate OSA and for those with severe OSA who cannot tolerate CPAP. Custom-fitted mandibular advancement devices have demonstrated reductions in the apnea-hypopnea index (AHI), improvements in daytime sleepiness scores, and — critically — higher rates of nightly use compared to CPAP in many patient populations.
For Canadian dental practices looking to serve this patient population, the clinical workflow involves collaborating with a sleep physician, obtaining a prescription for oral appliance therapy, taking impressions or digital scans for a custom device, titrating the mandibular advancement over several follow-up visits, and arranging a follow-up sleep study to confirm treatment efficacy.
What Canadian Practices Should Consider Before Adding Sleep Medicine Services
Dental sleep medicine is not a plug-and-play addition to a general practice. It requires investment in continuing education, diagnostic screening protocols, collaborative relationships with sleep physicians, and an understanding of the billing landscape.
In Ontario, oral appliance therapy is not currently covered by the Ontario Health Insurance Plan (OHIP). However, many private dental and extended health insurance plans do provide partial or full coverage for custom mandibular advancement devices when prescribed by a physician for diagnosed OSA. The Canadian Dental Care Plan (CDCP) benefit grids should be checked annually for any updates to sleep-related appliance coverage.
Equipment costs are manageable — unlike major capital purchases like CBCT scanners or CAD/CAM milling units, the primary investment is in education and the custom fabrication of devices through a dental laboratory. Chairside time per patient is moderate: initial consultation, impression or scan, device delivery, titration appointments, and annual follow-up.
Pro Tip: Build referral relationships with two or three sleep physicians in your area before launching dental sleep medicine services. A personal introduction — even a brief letter explaining your training and interest — goes further than a fax referral form. Many sleep physicians are actively seeking dental partners for oral appliance therapy.
Long-Term Considerations: Occlusal Changes and Monitoring
One area that systematic reviews have consistently flagged is the potential for long-term occlusal changes in patients using mandibular advancement devices. Studies have documented minor changes in overjet, overbite, and occlusal contacts in some patients after years of nightly MAD use. While these changes are generally considered clinically acceptable relative to the health risks of untreated OSA, they underscore the importance of ongoing dental monitoring.
Dentists providing oral appliance therapy should schedule annual or semi-annual follow-ups to assess bite changes, device fit, and continued treatment efficacy. Patients should be informed during the consent process that minor tooth movement is a documented possibility, allowing them to make an informed decision about the trade-off between sleep apnea management and potential occlusal effects.
The Canadian Opportunity
Canada's aging population, combined with increasing public awareness of sleep-disordered breathing, positions dental sleep medicine as a meaningful growth area for Canadian practices. The CDCP's expanding coverage footprint may eventually include oral appliance therapy as a recognized benefit — dentists who build the clinical infrastructure now will be prepared to serve this patient population if and when coverage expands.
For dental practices in Toronto and the GTA, the opportunity is particularly compelling. The region's dense population, high concentration of sleep clinics, and well-developed specialist referral networks make it an ideal environment for launching dental sleep medicine services. Dentists who can demonstrate training, maintain collaborative relationships with sleep physicians, and deliver evidence-based care will find themselves at the forefront of a field that is growing steadily and shows no signs of slowing down.
EBIKO Dental will continue monitoring developments in dental sleep medicine and reporting on evidence-based advances relevant to Canadian dental professionals.
Frequently Asked Questions
Q: Can dentists in Ontario diagnose obstructive sleep apnea?
No. Under RCDSO guidelines, Ontario dentists cannot diagnose obstructive sleep apnea. Diagnosis must come from a physician, typically through polysomnography or a home sleep apnea test. Dentists can screen patients using validated questionnaires and refer those with positive results to a sleep physician for formal evaluation.
Q: Is oral appliance therapy covered by insurance in Canada?
Oral appliance therapy is not covered by the Ontario Health Insurance Plan (OHIP). However, many private dental and extended health insurance plans provide partial or full coverage for custom mandibular advancement devices when prescribed by a physician for diagnosed OSA. Patients should check their individual plan benefits. The CDCP benefit grids should also be reviewed for any annual updates to appliance coverage.
Q: How effective are mandibular advancement devices compared to CPAP?
CPAP remains the gold standard for moderate-to-severe OSA in terms of AHI reduction. However, mandibular advancement devices have demonstrated meaningful reductions in AHI and improvements in daytime sleepiness for mild-to-moderate cases. Importantly, because patients tend to use oral appliances more consistently than CPAP, the real-world effectiveness gap narrows when nightly adherence is factored in. The January 2026 JADA consensus report confirms that MADs remain the evidence-based dental standard for OSA management.